InvestorLens

14491104 — ALEXANDER & BALDWIN INC NEW

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying 14491104?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong distribution · 0 buying vs 1 selling last quarter
8
Macro Tailwind
Macro conditions are mixed for this sector
52
Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their 14491104 position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence
  • +4 tracked investors reported holding 14491104 at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About ALEXANDER & BALDWIN INC NEW (14491104)

ALEXANDER & BALDWIN INC NEW (14491104) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by George Soros (Soros Fund Management), valued at $9M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in 14491104

67
/100
Institutional Accumulation
Added / Increased4
Reduced1
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track 14491104

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

14491104 Ownership Composition

How ALEXANDER & BALDWIN INC NEW is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
61% of tracked value
Institutions
4
tracked investors
Total Reported
$23.3M
combined 13F value
Sectors2
  • Other61.1%
  • Hedge Funds38.9%
Other(3)
61.1%
Hedge Funds(1)
38.9%

Tracked investors reporting 14491104

  • George SorosDec 31, 2025
    Soros Fund Management
    Shares
    440.2K
    Value
    $9.1M
    % Portfolio
    0.11%
  • Paul Tudor JonesDec 31, 2025
    Tudor Investment Corp
    Shares
    306.6K
    Value
    $6.3M
    % Portfolio
    0.01%
  • Izzy EnglanderDec 31, 2025
    Millennium Management
    Shares
    289.9K
    Value
    $6M
    % Portfolio
    0.00%
  • Ken GriffinDec 31, 2025
    Citadel Advisors
    Shares
    94K
    Value
    $1.9M
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold 14491104?
4 tracked institutional investors disclosed a position in 14491104 (ALEXANDER & BALDWIN INC NEW) in their most recent 13F filing.
Who is the largest institutional holder of 14491104?
George Soros, Soros Fund Management, holds the largest disclosed position in 14491104, valued at $9M.
Did institutional ownership of 14491104 increase or decrease?
Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 1 reduced, and 1 fully exited 14491104.
Where does this 14491104 ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.